Browsing by Author "Bosch, Francesc"

Now showing items 1-2 of 2

Obinutuzumab plus fludarabine and cyclophosphamide in previously untreated, fit patients with chronic lymphocytic leukemia: a subgroup analysis of the GREEN study

Bosch, Francesc; Cantin, Guy; Cortelezzi, Agostino; Knauf, Wolfgang; Tiab, Mourad; Turgut, Mehmet; Leblond, Veronique (Nature Publishing Group, 2020)

GREEN (NCT01905943) is a nonrandomized, open-label, single-arm, phase 3b study investigating the safety and efficacy of obinutuzumab alone or in combination with chemotherapy in chronic lymphocytic leukemia (CLL). We report ...
Preliminary Safety Results from the Phase IIIb GREEN Study of Obinutuzumab (GA101) Alone or in Combination with Chemotherapy for Previously Untreated or Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

Bosch, Francesc; Illmer, Thomas; Turgut, Mehmet; Cortelezzi, Agostino; Lasserre, Susan F.; Truppel-Hartmann, Anna; Stilgenbauer, Stephan (Amer Soc Hematology, 2014)

…